Patients with melanoma metastases at cutaneous and subcutaneous sites are highly susceptible to interleukin-2-based therapy (Q73519509)
Jump to navigation
Jump to search
scientific article published on 01 January 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Patients with melanoma metastases at cutaneous and subcutaneous sites are highly susceptible to interleukin-2-based therapy |
scientific article published on 01 January 2001 |
Statements
Patients with melanoma metastases at cutaneous and subcutaneous sites are highly susceptible to interleukin-2-based therapy (English)
Chang E
1 January 2001